Suppr超能文献

强烈增加 BACE 活性条件下人类神经元中 Aβ 分泌减少。

Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity.

机构信息

Chair for in vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.

出版信息

J Neurochem. 2018 Oct;147(2):256-274. doi: 10.1111/jnc.14467. Epub 2018 Sep 26.

Abstract

The initial step in the amyloidogenic cascade of amyloid precursor protein (APP) processing is catalyzed by beta-site APP-cleaving enzyme (BACE), and this protease has increased activities in affected areas of Alzheimer's disease brains. We hypothesized that altered APP processing, because of augmented BACE activity, would affect the actions of direct and indirect BACE inhibitors. We therefore compared post-mitotic human neurons (LUHMES) with their BACE-overexpressing counterparts (BLUHMES). Although β-cleavage of APP was strongly increased in BLUHMES, they produced less full-length and truncated amyloid beta (Aβ) than LUHMES. Moreover, low concentrations of BACE inhibitors decreased cellular BACE activity as expected, but increased Aβ levels. Several other approaches to modulate BACE activity led to a similar, apparently paradoxical, behavior. For instance, reduction in intracellular acidification by bepridil increased Aβ production in parallel with decreased BACE activity. In contrast to BLUHMES, the respective control cells (LUHMES or BLUHMES with catalytically inactive BACE) showed conventional pharmacological responses. Other non-canonical neurochemical responses (so-called 'rebound effects') are well-documented for the Aβ pathway, especially for γ-secretase: a partial block of its activity leads to an increased Aβ secretion by some cell types. We therefore compared LUHMES and BLUHMES regarding rebound effects of γ-secretase inhibitors and found an Aβ rise in LUHMES but not in BLUHMES. Thus, different cellular factors are responsible for the γ-secretase- versus BACE-related Aβ rebound. We conclude that increased BACE activity, possibly accompanied by an altered cellular localization pattern, can dramatically influence Aβ generation in human neurons and affect pharmacological responses to secretase inhibitors. OPEN PRACTICES: Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/.

摘要

淀粉样前体蛋白(APP)加工的淀粉样蛋白形成级联反应的第一步是由β位 APP 切割酶(BACE)催化的,这种蛋白酶在阿尔茨海默病大脑受影响区域的活性增加。我们假设,由于 BACE 活性的增加,APP 加工的改变会影响直接和间接 BACE 抑制剂的作用。因此,我们比较了有丝分裂后人类神经元(LUHMES)与其 BACE 过表达对应物(BLUHMES)。尽管 BLUHMES 中β-切割 APP 的活性大大增强,但它们产生的全长和截断的淀粉样β(Aβ)比 LUHMES 少。此外,低浓度的 BACE 抑制剂如预期的那样降低了细胞内 BACE 活性,但增加了 Aβ 水平。其他几种调节 BACE 活性的方法导致了类似的、明显矛盾的行为。例如,通过贝普里利抑制细胞内酸化会增加 Aβ 的产生,同时降低 BACE 活性。与 BLUHMES 相反,各自的对照细胞(LUHMES 或具有无催化活性 BACE 的 BLUHMES)表现出常规的药物反应。其他非典型神经化学反应(所谓的“反弹效应”)在 Aβ 途径中得到了很好的记录,特别是对于 γ-分泌酶:其活性的部分阻断会导致一些细胞类型 Aβ 的分泌增加。因此,我们比较了 LUHMES 和 BLUHMES 关于 γ-分泌酶抑制剂的反弹效应,发现 LUHMES 中 Aβ 升高,但 BLUHMES 中没有。因此,不同的细胞因子负责 γ-分泌酶与 BACE 相关的 Aβ 反弹。我们得出结论,BACE 活性的增加,可能伴随着细胞定位模式的改变,可显著影响人类神经元中 Aβ 的产生,并影响对分泌酶抑制剂的药物反应。开放实践:本研究获得了开放科学实践徽章。更多信息请访问:https://cos.io/our-services/open-science-badges/。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验